January 23, 2018 / 1:11 PM / Updated 8 minutes ago BRIEF-Biocancell Announces Terms Of $25 Million Funding Round Reuters Staff 
Jan 23 (Reuters) - Biocancell Ltd: * BIOCANCELL ANNOUNCES TERMS OF $25 MILLION FUNDING ROUND 
* BIOCANCELL LTD - EXECUTED NON-BINDING TERM SHEET FOR PRIVATE EQUITY INVESTMENT IN CO OF ABOUT $25 MILLION; INVESTMENT WILL BE PRICED AT NIS 1.60 PER SHARE​ 
* BIOCANCELL LTD - ‍FUNDRAISING PLANS ARE DESIGNED TO FUND CO‘S INITIATION OF CLINICAL TRIALS OF BC-819 IN EARLY STAGE BLADDER CANCER Source text for Eikon: Further company coverage: